Literature DB >> 34391866

Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.

Huiming Jiang1, Haibin Chen2, Pei Wan3, Nanhui Chen4.   

Abstract

Kidney renal clear cell carcinoma (KIRC) is the subtype pf kidney cancer having the highest mortality as well as the highest potential of invasion and metastasis. The expression of HADH, encoding a key enzyme in fatty acid β-oxidation, has rarely been reported to correlate with prognosis and immune infiltration in cancers. This study aimed to explore the prognostic value of HADH in patients with KIRC. Gene expression profiles and clinical data of KIRC patients were acquired from The Cancer Genome Atlas. We compared the expression of HADH between KIRC tissues and normal tissues. Then, the relationship between HADH expression and the clinicopathological characteristics (survival, age, gender, stage, and grade) of KIRC was explored. Data from several online databases and paraffin-embedded specimens from two cohorts were used for external validation (10 cases from Meizhou People's Hospital and another 75 cases from a tissue chip, with both cohorts including KIRC samples and paired normal tissues). We also predicted the fractions of tumor-infiltrating immune cells (TIICs) in various tissues using CIBERSORT. Next, we estimated the prognostic value of differences in TIIC proportions between the high and low HADH expression groups. Finally, gene set enrichment analysis (GSEA) was performed to explore the potential mechanisms by which HADH expression influences patient survival. The expression of HADH was significantly lower in KIRC tissue than in normal tissue. Decreased expression of HADH was significantly correlated with high histologic grade, advanced stage, and poor prognosis. The differential expression of HADH was validated at the protein level by immunohistochemistry. Multivariate Cox regression analysis indicated that HADH was an independent prognostic factor for KIRC. In addition, HADH expression was significantly associated with the accumulation of several TIICs, especially regulatory T cells. Finally, GSEA revealed that the transcriptome of the low HADH expression group was significantly enriched in genes involved in not only epithelial-mesenchymal transition and inflammatory response but also TNF-α, IL-6-JAK-STAT3, and interferon-γ signaling. In conclusion, our study demonstrated that decreased expression of HADH is related to poor prognosis and immune infiltration in KIRC; this finding may provide crucial information for the development of immunotherapies.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HADH; Immune infiltration; Kidney renal clear cell carcinoma; Prognosis; TCGA

Mesh:

Year:  2021        PMID: 34391866     DOI: 10.1016/j.ygeno.2021.08.008

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption.

Authors:  Lide Tao; Xiangmin Ding; Lele Yan; Guangcai Xu; Peijian Zhang; Anlai Ji; Lihong Zhang
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

2.  Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.

Authors:  Zhuolun Sun; Wen Tao; Xudong Guo; Changying Jing; Mingxiao Zhang; Zhenqing Wang; Feng Kong; Ning Suo; Shaobo Jiang; Hanbo Wang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

3.  Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma.

Authors:  Tong Zhu; Tianyu Wang; Zijun Feng; Furong Gao; Jieping Zhang; Caixia Jin; Haibin Tian; Jingying Xu; Hao Chen; Qingjian Ou; Juan Wang; Guotong Xu; Lixia Lu
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.